When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Frontotemporal dementia

最后审阅: 20 Aug 2025
最后更新: 19 Sep 2025

小结

定义

病史和体格检查

关键诊断因素

  • coarsening of personality, social behavior, and habits
  • progressive loss of language fluency or comprehension
  • development of memory impairment, disorientation, or apraxias
  • progressive self-neglect and abandonment of work, activities, and social contacts
完整详情

其他诊断因素

  • early age at onset
  • family history of frontotemporal dementia (FTD)
  • altered eating habits
  • inattentiveness, puerile preoccupations, economy of effort, impulsive responding, and compulsive behaviors
  • signs of amyotrophic lateral sclerosis (ALS)
  • parkinsonian symptoms
  • fasciculations, atrophy, hyperreflexia, and other signs of motor neuron disease
  • glabellar, snout, sucking, rooting, or grasp reflex
  • loss of bladder and bowel control
完整详情

危险因素

  • mutations in MAPT gene
  • mutations in GRN gene
  • mutations in C9orf72 gene
  • other mutations
  • traumatic brain injury
  • post-traumatic stress disorder (PTSD)
完整详情

诊断性检查

首要检查

  • cognitive testing
  • brain MRI
  • brain CT
  • CBC
  • serum CRP
  • serum thyroid-stimulating hormone (TSH)
  • free thyroxine (T4)
  • metabolic panel
  • serum BUN
  • serum creatinine
  • LFTs
  • serum vitamin B12 levels
  • serum folate levels
  • syphilis serology
  • HIV testing
  • serum enzyme-linked immunosorbent assay
完整详情

需考虑的检查

  • brain fluorodeoxyglucose (FDG)-PET/CT
  • brain perfusion single-photon emission computed tomography (SPECT)
  • brain amyloid PET/CT
  • brain biopsy
  • genetic testing
  • connective tissue panel
  • serum erythrocyte sedimentation rate
  • electroencephalogram (EEG)
  • electromyogram (EMG)
完整详情

新兴检查

  • fluid biomarkers

治疗流程

持续性治疗

all patients

撰稿人

作者

Raghava Kurup Radhakrishnan, DPM(NIMHANS), DNB(Psych), FRCPsych

Consultant Psycho-geriatrician

Waitemata District Health Board

Auckland

New Zealand

利益声明

RKR serves as an advisory board member for the Australian and New Zealand Journal of Psychiatry.

Rommel Dawith, MBChB, FRANZCP, FFPOA

Psychiatrist of Old Age

Waitemata District Health Board

Auckland

New Zealand

利益声明

RD declares that he has no competing interests.

鸣谢

Dr Raghava Kurup Radhakrishnan and Dr Rommel Dawith would like to gratefully acknowledge Dr Sachin Jauhari, Dr Lawrence Whalley, and Dr Chiadi Onyike, the previous contributors to this topic, and colleagues Dr Ann Boston (clinical psychologist), Dr Zara Godinovich (clinical psychologist), and Diane Ellis (clinical nurse specialist) for their suggestions.

利益声明

SJ, LW, CO, AB, ZG, and DE declare that they have no competing interests.

同行评议者

Daniel Kaufer, MD

Director

Memory Disorders Program

Department of Neurology

University of North Carolina at Chapel Hill

NC

利益声明

DK has received research support, speaking honoraria, and consulting fees from Eisai, Forest Laboratories, Johnson & Johnson, Medivation, Novartis, Ortho-McNeil, and Pfizer.

Bruce L. Miller, MD

Professor of Neurology

University of California

San Francisco

CA

利益声明

BLM declares that he has no competing interests.

Philip Scheltens, MD, PhD

Professor of Neurology

Department of Neurology/Alzheimer Center

VU University Medical Center

Amsterdam

The Netherlands

利益声明

PS declares that he has no competing interests.

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

参考文献

Our in-house evidence and editorial teams collaborate with international expert contributors and peer reviewers to ensure that we provide access to the most clinically relevant information possible.

关键文献

Rascovsky K, Hodges JR, Knopman D, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain. 2011 Sep;134(Pt 9):2456-77.全文  摘要

American College of Radiology. ACR appropriateness criteria: dementia. 2024 [internet publication].全文

Buoli M, Serati M, Caldiroli A, et al. Pharmacological management of psychiatric symptoms in frontotemporal dementia: a systematic review. J Geriatr Psychiatry Neurol. 2017 May;30(3):162-9. 摘要

Reus VI, Fochtmann LJ, Eyler AE, et al. The American Psychiatric Association practice guideline on the use of antipsychotics to treat agitation or psychosis in patients with dementia. Am J Psychiatry. 2016 May 1;173(5):543-6.全文  摘要

参考文献

A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.
  • 鉴别诊断

    • Alzheimer disease
    • Dementia with Lewy bodies (DLB)
    • Vascular dementia
    更多 鉴别诊断
  • 指南

    • European intersocietal recommendations for the biomarker-based diagnosis of neurocognitive disorders
    • ACR appropriateness criteria: dementia
    更多 指南
  • 患者教育信息

    Caring for someone with dementia

    Dementia: frontotemporal dementia

    更多 患者教育信息
  • padlock-locked登录或订阅即可浏览 BMJ Best Practice 临床实践完整内容

内容使用需遵循免责声明